Eisai, Biogen receives U.S. FDA approval for Alzheimer’s drug, applies for full approval January 7, 2023
Congressional report: U.S. FDA broke own protocols in approving Biogen Alzheimer’s drug December 30, 2022December 30, 2022
Positive Moderna, Merck cancer vaccine data advances mRNA promise, shares rise December 13, 2022December 13, 2022
U.S. aims to hobble China’s chip industry with sweeping new export rules October 7, 2022October 7, 2022
Eisai, Biogen say Alzheimer’s drug succeeds in slowing cognitive decline September 28, 2022September 28, 2022